Bellevue Asset Management (Switzerland)’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$5.06M Buy
225,000
+25,223
+13% +$499K 0.77% 47
2015
Q3
$4.67M Buy
199,777
+69,777
+54% +$1.93M 0.76% 45
2015
Q2
$3.72M Buy
130,000
+56,200
+76% +$1.47M 0.52% 64
2015
Q1
$1.91M Buy
+73,800
New +$1.69M 0.27% 89

Other funds holding XENT

Bellevue Asset Management (Switzerland)'s XENT Position: Q4 2015 in Review

Bellevue Asset Management (Switzerland) increased its Intersect ENT, Inc (XENT) stake by 13% in Q4 2015, buying an estimated $499K and bringing the position to 225,000 shares worth $5.06M. The position accounts for 0.77% of the portfolio, ranked #47.

Bellevue Asset Management (Switzerland) first reported a position in XENT in Q1 2015 and has held it in 4 quarters since. 115 funds tracked by Wall St. Rank hold XENT as of Q4 2015.

  • Bellevue Asset Management (Switzerland) held 225,000 shares of Intersect ENT, Inc worth $5.06M as of Q4 2015.
  • Bellevue Asset Management (Switzerland) bought 25,223 Intersect ENT, Inc shares in Q4 2015, an estimated $499K.
  • Intersect ENT, Inc made up 0.77% of Bellevue Asset Management (Switzerland)'s portfolio in Q4 2015, its #47 holding.
  • Bellevue Asset Management (Switzerland) first reported a position in Intersect ENT, Inc in Q1 2015 and has held it in 4 quarters since.
  • 115 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q4 2015.

Based on Bellevue Asset Management (Switzerland)'s 13F filing for Q4 2015, filed 12 Feb 2016.